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Postmortem molecular analysis of the human brain during development and aging suggests there are epigenetic 
changes reflecting early life experiences. This includes changes in the expression of non-coding RNAs such as 
microRNA. These molecules alter the regulation of gene expression and can interact with underlying genetic risk 
factors, contributing to neurological and neuropsychiatric syndromes such as schizophrenia. Recent evidence 
suggests that these dynamic and influential molecules play an important role in both brain development and the 
cellular response to stress. In our recent studies, we investigate the role of microRNA in the brains’ response to 
maternal immune activation and adolescent cannabinoid exposure, alone and in combination, as both have been 
identified as environmental risk factors for this disorder. We found that combined exposure to significantly 
altered microRNA expression in the left hemisphere of the entorhinal cortex as compared to the right. These 
changes were dominated by a large subgroup of microRNA transcribed from a single imprinted locus on 
chromosome 6q32 that is associated with schizophrenia. These changes correlated with altered gene expression 
in the combined treatment group, with microRNA-gene interactions predicted to regulate neuronal growth and 
differentiation; development of specific cortical layers; synaptic plasticity and transmission; axonogenesis; 
gamma-aminobutyric acid neurotransmitter system; and learning and memory formation. These findings 
suggested that the interaction of both an early and late environmental insult enhances changes in offspring 
microRNA expression in the brain with possible outcomes relevant to neurological disorders in adulthood. 
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Development of the central nervous system (CNS) is a 
complex and ongoing process spanning embryogenesis to 
early adulthood. During this critical period an elaborate 
network of neural connections is established and maintained 
via activity-dependent remodelling. The developmental 
processes that lead to functional synapses and their capacity 
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to undergo activity-dependent remodelling and synaptic 
plasticity are complex, regulated by thousands of proteins 
and involve a combination of genetic and epigenetic 
influences. In humans the dysregulation of these processes 
can lead to problems with neural circuitry which can 
manifest as a range of neurodevelopmental syndromes, such 
as fragile X mental retardation, and psychiatric disorders, 
such as schizophrenia and bipolar disorder. Although there is 
a strong, underlying genetic component, epidemiological 
studies show that exposure to environmental stress 
significantly elevates the risk for developing 
neurodevelopmental disorders such as schizophrenia [1-3]. 
However, the extent and mechanisms by which the 
environment produces these effects in the brain remains 
incompletely understood.  
Studies now indicate an emerging role for microRNA 
(miRNA) in the cellular response to stress, with miRNA 
activation vital to augment CNS recovery from damage in a 
controlled manner [4-6]. These short, non-coding sequences 
are abundant in the human brain and have many diverse and 
important roles in the CNS [7-9]. MiRNA are recognised to 
play a critical role in modifying gene expression by 
repressing translation or inducing mRNA degradation [10]. 
With each miRNA able to modulate the expression of 
hundreds of genes, they are predicted to 
post-transcriptionally regulate ~80% of all protein-coding 
genes and therefore to be involved in all biological processes. 
Environmental insults that can affect miRNA expression 
therefore have the potential to alter numerous processes and 
affect normal brain development. In fact, studies show that 
exposure to environmental stressors can not only bring about 
changes in expression of miRNA involved in the 
development and function of the CNS, it can also alter the 
expression of genes involved in the miRNA biogenesis 
machinery [11-13]. 
However, in order to understand the role of miRNA in the 
response to environmental stress it is first necessary to 
understand their role in gene regulation during 
neurodevelopment. We recently provided the first global 
characterization of both miRNA and mRNA expression at 
various stages in the developing rodent brain. By comparing 
miRNA and gene expression in the mesencephalon, which 
develops relatively early, with the telencephalon, which 
develops later [14], we demonstrated both the temporal and 
regional specificity of miRNA and their target gene 
expression during neurodevelopment [15]. Throughout 
development, 87% of expressed miRNA underwent 
significant changes, with the highest level of change 
occurring during early development (embryonic days (E) 
12-15). MiRNA expression in the telencephalon was 
significantly lower than the mesencephalon at E12 consistent 
with the delayed development of this region. We also 
observed 32 miRNA that were exclusively expressed in the 
telencephalon during early brain development (E12) that had 
predicted functions in neurodevelopmental processes. These 
findings support the concept that the developing brain is 
sensitive to environmental factors at specific developmental 
stages, which can lead to differences in the adult brain as a 
result of altered developmental processes (reviewed by 
Dudley et al., 2011 [16]). 
To further understand the role of miRNA in the 
developing brains’ response to environmental stress, we 
examined the impact of an early and late environmental 
stressor, both alone and in combination, on neural miRNA 
and gene expression in the entorhinal cortex (EC) [17, 18]. This 
brain region is located in the temporal lobe and is vital for 
the mediation of conscious memory [19]. Severe alteration of 
the EC is associated with several disorders of the human 
brain, importantly Alzheimer’s disease, bipolar disorder, 
temporal lobe epilepsy and schizophrenia [20-25]. We 
examined the effects of maternal immune activation (MIA) 
and adolescent cannabinoid exposure (ACE), both of which 
have been documented to be strongly associated with an 
increased risk of developing schizophrenia [3, 26-28] and found 
that the combination of MIA and ACE induced significant 
differences in miRNA expression, whereas only a small 
effect was observed for each treatment alone. Interestingly, 
this effect occurred predominantly in the left hemisphere 
(98%), the same hemisphere primarily altered in 
schizophrenia, and was dominated by a large subgroup of 
miRNA differentially transcribed from a single imprinted 
locus on chromosome 6q32 [18]. In humans, the syntenic 
locus (14q32) encodes a large proportion of miRNAs 
differentially expressed in schizophrenia [29]. Similarly, 
alterations in gene expression occurred primarily in the 
combined MIA-ACE group (99%). MiRNA with altered 
expression in the combined MIA-ACE group were predicted 
to have evolutionary conserved interactions with a large 
proportion of the downregulated genes in this treatment 
group. MiRNA-gene interactions were identified as highly 
enriched in the gamma-aminobutyric acid (GABA) signalling 
pathway, synaptic transmission, transmission of nerve 
impulse and cell-cell signalling, processes repeatedly 
implicated in the pathophysiology of schizophrenia. These 
genes encode proteins with prominent functions in neuronal 
growth and differentiation; development of specific cortical 
layers; synaptic plasticity and transmission; axonogenesis; 
GABA neurotransmitter system; and learning and memory 
formation. These changes in gene and miRNA expression 
corresponded with neuropathological alteration in the 
entorhinal cortex with significant change in radio ligand 
binding to the serotonin 5HT1A receptor in the brains of 
adolescent rats exposed to combined prenatal and postnatal 
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insult. 
These findings indicate that the interaction of both an 
early and late environmental insult can enhance changes in 
offspring miRNA expression in the EC that correlate with 
alterations in gene expression. In response to environmental 
stress, it is highly likely that miRNA play a major role in the 
developmental abnormalities that underlie numerous 
neurological disorders. In particular, abnormalities in the EC 
may contribute to the aberrant behaviours associated with 
these disorders, directly affecting cognitive processes that are 
so often impaired in these conditions. Understanding the 
dynamics that may mediate a person’s predisposition to 
stress-induced neuropathology has major human health 
benefits and is an important area of research. Therefore, by 
linking miRNA to key biological processes related to 
neuropathology in response to environmental stress, we 
provide attractive targets for drug design that may offer an 
alternative to current medications with reduced side effects. 
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